These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
369 related articles for article (PubMed ID: 29171999)
1. ABC Transporters Are Key Players in Alzheimer's Disease. Pereira CD; Martins F; Wiltfang J; da Cruz E Silva OAB; Rebelo S J Alzheimers Dis; 2018; 61(2):463-485. PubMed ID: 29171999 [TBL] [Abstract][Full Text] [Related]
2. Age-Dependent Regulation of the Blood-Brain Barrier Influx/Efflux Equilibrium of Amyloid-β Peptide in a Mouse Model of Alzheimer's Disease (3xTg-AD). Do TM; Dodacki A; Alata W; Calon F; Nicolic S; Scherrmann JM; Farinotti R; Bourasset F J Alzheimers Dis; 2016; 49(2):287-300. PubMed ID: 26484906 [TBL] [Abstract][Full Text] [Related]
3. Role of ABC transporters in the pathogenesis of Alzheimer's disease. Abuznait AH; Kaddoumi A ACS Chem Neurosci; 2012 Nov; 3(11):820-31. PubMed ID: 23181169 [TBL] [Abstract][Full Text] [Related]
4. ABCG2 is upregulated in Alzheimer's brain with cerebral amyloid angiopathy and may act as a gatekeeper at the blood-brain barrier for Abeta(1-40) peptides. Xiong H; Callaghan D; Jones A; Bai J; Rasquinha I; Smith C; Pei K; Walker D; Lue LF; Stanimirovic D; Zhang W J Neurosci; 2009 Apr; 29(17):5463-75. PubMed ID: 19403814 [TBL] [Abstract][Full Text] [Related]
5. ABCG2- and ABCG4-mediated efflux of amyloid-β peptide 1-40 at the mouse blood-brain barrier. Do TM; Noel-Hudson MS; Ribes S; Besengez C; Smirnova M; Cisternino S; Buyse M; Calon F; Chimini G; Chacun H; Scherrmann JM; Farinotti R; Bourasset F J Alzheimers Dis; 2012; 30(1):155-66. PubMed ID: 22391220 [TBL] [Abstract][Full Text] [Related]
6. The Interplay of ABC Transporters in Aβ Translocation and Cholesterol Metabolism: Implicating Their Roles in Alzheimer's Disease. Behl T; Kaur I; Sehgal A; Kumar A; Uddin MS; Bungau S Mol Neurobiol; 2021 Apr; 58(4):1564-1582. PubMed ID: 33215389 [TBL] [Abstract][Full Text] [Related]
7. Local perfusion of capillaries reveals disrupted beta-amyloid homeostasis at the blood-brain barrier in Tg2576 murine Alzheimer's model. Hanafy AS; Lamprecht A; Dietrich D Fluids Barriers CNS; 2023 Nov; 20(1):85. PubMed ID: 37993886 [TBL] [Abstract][Full Text] [Related]
8. The impact of ATP-binding cassette transporters in the diseased brain: Context matters. Baltira C; Aronica E; Elmquist WF; Langer O; Löscher W; Sarkaria JN; Wesseling P; de Gooijer MC; van Tellingen O Cell Rep Med; 2024 Jun; 5(6):101609. PubMed ID: 38897176 [TBL] [Abstract][Full Text] [Related]
9. Therapeutic drugs modulate ATP-Binding cassette transporter-mediated transport of amyloid beta Shubbar MH; Penny JI Eur J Pharmacol; 2020 May; 874():173009. PubMed ID: 32061744 [TBL] [Abstract][Full Text] [Related]
10. MDR1-P-glycoprotein (ABCB1)-mediated disposition of amyloid-β peptides: implications for the pathogenesis and therapy of Alzheimer's disease. Jedlitschky G; Vogelgesang S; Kroemer HK Clin Pharmacol Ther; 2010 Oct; 88(4):441-3. PubMed ID: 20856238 [TBL] [Abstract][Full Text] [Related]
11. Alzheimer's and ABC transporters--new opportunities for diagnostics and treatment. Pahnke J; Langer O; Krohn M Neurobiol Dis; 2014 Dec; 72 Pt A():54-60. PubMed ID: 24746857 [TBL] [Abstract][Full Text] [Related]
12. P-glycoprotein: a role in the export of amyloid-β in Alzheimer's disease? Chai AB; Leung GKF; Callaghan R; Gelissen IC FEBS J; 2020 Feb; 287(4):612-625. PubMed ID: 31750987 [TBL] [Abstract][Full Text] [Related]
13. ATP-binding cassette transporters P-glycoprotein and breast cancer related protein are reduced in capillary cerebral amyloid angiopathy. Carrano A; Snkhchyan H; Kooij G; van der Pol S; van Horssen J; Veerhuis R; Hoozemans J; Rozemuller A; de Vries HE Neurobiol Aging; 2014 Mar; 35(3):565-75. PubMed ID: 24138987 [TBL] [Abstract][Full Text] [Related]
14. Blood-Brain Barrier ABC-transporter P-glycoprotein in Alzheimer's Disease: Still a Suspect? van Assema DM; van Berckel BN Curr Pharm Des; 2016; 22(38):5808-5816. PubMed ID: 27494062 [TBL] [Abstract][Full Text] [Related]
15. Role of ABC transporters in the pathology of Alzheimer's disease. Zhao Y; Hou D; Feng X; Lin F; Luo J Rev Neurosci; 2017 Feb; 28(2):155-159. PubMed ID: 27997355 [TBL] [Abstract][Full Text] [Related]
16. ABCA7 Downregulation Modifies Cellular Cholesterol Homeostasis and Decreases Amyloid-β Peptide Efflux in an in vitro Model of the Blood-Brain Barrier. Lamartinière Y; Boucau MC; Dehouck L; Krohn M; Pahnke J; Candela P; Gosselet F; Fenart L J Alzheimers Dis; 2018; 64(4):1195-1211. PubMed ID: 30010117 [TBL] [Abstract][Full Text] [Related]
17. Dysfunction of ABC transporters at the blood-brain barrier: Role in neurological disorders. Gil-Martins E; Barbosa DJ; Silva V; Remião F; Silva R Pharmacol Ther; 2020 Sep; 213():107554. PubMed ID: 32320731 [TBL] [Abstract][Full Text] [Related]
18. Blood-brain-barrier models for the investigation of transporter- and receptor-mediated amyloid-β clearance in Alzheimer's disease. Pflanzner T; Kuhlmann CR; Pietrzik CU Curr Alzheimer Res; 2010 Nov; 7(7):578-90. PubMed ID: 20704558 [TBL] [Abstract][Full Text] [Related]
19. Proteomic Quantification of Human Blood-Brain Barrier SLC and ABC Transporters in Healthy Individuals and Dementia Patients. Al-Majdoub ZM; Al Feteisi H; Achour B; Warwood S; Neuhoff S; Rostami-Hodjegan A; Barber J Mol Pharm; 2019 Mar; 16(3):1220-1233. PubMed ID: 30735053 [TBL] [Abstract][Full Text] [Related]
20. ABCA5 regulates amyloid-β peptide production and is associated with Alzheimer's disease neuropathology. Fu Y; Hsiao JH; Paxinos G; Halliday GM; Kim WS J Alzheimers Dis; 2015; 43(3):857-69. PubMed ID: 25125465 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]